{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T12:48:18Z","timestamp":1725367698062},"reference-count":42,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"12","license":[{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2022,12,9]]},"DOI":"10.1167\/tvst.11.12.8","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T14:31:01Z","timestamp":1670596261000},"page":"8","source":"Crossref","is-referenced-by-count":1,"title":["Suppression of Pathological Ocular Neovascularization by a Small Molecular Multi-Targeting Kinase Inhibitor, DCZ19903"],"prefix":"10.1167","volume":"11","author":[{"given":"Jingjuan","family":"Ding","sequence":"first","affiliation":[{"name":"The Affiliated Eye Hospital, Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Drug Research, Shanghai, China"},{"name":"Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiying","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Affiliated Eye Hospital, Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijian","family":"Xu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Drug Research, Shanghai, China"},{"name":"Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuyang","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Affiliated Eye Hospital, Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Ye","sequence":"additional","affiliation":[{"name":"The Affiliated Eye Hospital, Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siguo","family":"Feng","sequence":"additional","affiliation":[{"name":"The Affiliated Eye Hospital, Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Jiang","sequence":"additional","affiliation":[{"name":"The Affiliated Eye Hospital, Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiliang","family":"Zhu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Drug Research, Shanghai, China"},{"name":"Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biao","family":"Yan","sequence":"additional","affiliation":[{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China"},{"name":"National Health Commission (NHC) Key Laboratory of Myopia, Fudan University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1167\/tvst.5.2.10","article-title":"VEGF and intraocular neovascularization: from discovery to therapy","volume":"5","author":"Ferrara","year":"2016","journal-title":"Transl Vis Sci Technol"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"8940","DOI":"10.3390\/ijms21238940","article-title":"Rice bran and vitamin B6 suppress pathological neovascularization in a murine model of age-related macular degeneration as novel HIF inhibitors","volume":"21","author":"Ibuki","year":"2020","journal-title":"Int J Mol Sci"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"4809","DOI":"10.3390\/ijms22094809","article-title":"Concurrent physiological and pathological angiogenesis in retinopathy of prematurity and emerging therapies","volume":"22","author":"Dai","year":"2021","journal-title":"Int J Mol Sci"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1161\/CIRCULATIONAHA.111.040337","article-title":"Wnt signaling mediates pathological vascular growth in proliferative retinopathy","volume":"124","author":"Chen","year":"2011","journal-title":"Circulation"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10456-016-9497-6","article-title":"Bone marrow-derived cells in ocular neovascularization: contribution and mechanisms","volume":"19","author":"Gao","year":"2016","journal-title":"Angiogenesis"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1172\/JCI29683","article-title":"Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy","volume":"116","author":"Ritter","year":"2006","journal-title":"J Clin Invest"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"D963","DOI":"10.1093\/nar\/gku1139","article-title":"PubAngioGen: a database and knowledge for angiogenesis and related diseases","volume":"43","author":"Li","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"eaay3566","DOI":"10.1126\/sciadv.aay3566","article-title":"Epac1 inhibition ameliorates pathological angiogenesis through coordinated activation of Notch and suppression of VEGF signaling","volume":"6","author":"Liu","year":"2020","journal-title":"Sci Adv"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4062\/biomolther.2013.113","article-title":"VEGF-VEGFR signals in health and disease","volume":"22","author":"Shibuya","year":"2014","journal-title":"Biomol Ther (Seoul)"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ophtha.2012.07.038","article-title":"Vascular endothelial growth factor a in intraocular vascular disease","volume":"120","author":"Miller","year":"2013","journal-title":"Ophthalmology"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.molmed.2014.10.005","article-title":"Seeing through VEGF: innate and adaptive immunity in pathological angiogenesis in the eye","volume":"21","author":"Sene","year":"2015","journal-title":"Trends Mol Med"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"100906","DOI":"10.1016\/j.preteyeres.2020.100906","article-title":"Incomplete response to anti-VEGF therapy in neovascular AMD: exploring disease mechanisms and therapeutic opportunities","volume":"82","author":"Mettu","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/j.ophtha.2016.03.045","article-title":"Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: the comparison of age-related macular degeneration treatments trials","volume":"123","author":"Maguire","year":"2016","journal-title":"Ophthalmology"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.ijbiomac.2021.03.075","article-title":"Role of receptor tyrosine kinases mediated signal transduction pathways in tumor growth and angiogenesis-new insight and futuristic vision","volume":"180","author":"Huang","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1016\/j.bbagen.2018.08.013","article-title":"Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K\/AKT and MAPK\/ERK1\/2 pathway","volume":"1862","author":"Sadremomtaz","year":"2018","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cmet.2013.11.008","article-title":"Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis","volume":"19","author":"Schoors","year":"2014","journal-title":"Cell Metab"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1167\/iovs.18-25745","article-title":"Nrf2 Activator RS9 suppresses pathological ocular angiogenesis and hyperpermeability","volume":"60","author":"Nakamura","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/nm.3668","article-title":"PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis","volume":"20","author":"Xie","year":"2014","journal-title":"Nat Med"},{"key":"bib20","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.2174\/0929867324666170112112734","article-title":"Kinase inhibitors in multitargeted cancer therapy","volume":"24","author":"Gentile","year":"2017","journal-title":"Curr Med Chem"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1021\/acs.jmedchem.1c00963","article-title":"Small molecule kinase inhibitor drugs (1995-2021): medical indication, pharmacology, and synthesis","volume":"65","author":"Ayala-Aguilera","year":"2022","journal-title":"J Med Chem"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.3390\/cancers14081994","article-title":"MBP-11901 inhibits tumor growth of hepatocellular carcinoma through multitargeted inhibition of receptor tyrosine kinases","volume":"14","author":"Park","year":"2022","journal-title":"Cancers (Basel)"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1001\/jamaoncol.2018.3039","article-title":"Effect of anlotinib as a thirdline or further treatment on overall survival of patients with advanced non-small cell lung cancer: The ALTER 0303 phase 3 randomized clinical trial","volume":"4","author":"Han","year":"2018","journal-title":"JAMA Oncol"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.7150\/thno.48662","article-title":"Nanomedicine of tyrosine kinase inhibitors","volume":"11","author":"Smidova","year":"2021","journal-title":"Theranostics"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"445101","DOI":"10.1088\/0957-4484\/22\/44\/445101","article-title":"Efficient nanoparticle mediated sustained RNA interference in human primary endothelial cells","volume":"22","author":"Mukerjee","year":"2011","journal-title":"Nanotechnology"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1517\/14712598.4.9.1395","article-title":"Ocular neovascularisation and excessive vascular permeability","volume":"4","author":"Campochiaro","year":"2004","journal-title":"Expert Opin Biol Ther"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"dmm049029","DOI":"10.1242\/dmm.049029","article-title":"Suppressing STAT3 activity protects the endothelial barrier from VEGF-mediated vascular permeability","volume":"14","author":"Wang","year":"2021","journal-title":"Dis Model Mech"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1172\/JCI89893","article-title":"Mast cell hyperactivity underpins the development of oxygen-induced retinopathy","volume":"127","author":"Matsuda","year":"2017","journal-title":"J Clin Invest"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"6229","DOI":"10.1016\/j.biomaterials.2013.04.061","article-title":"Post-translational regulation of a hypoxia-responsive VEGF plasmid for the treatment of myocardial ischemia","volume":"34","author":"Won","year":"2013","journal-title":"Biomaterials"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.22336\/rjo","article-title":"Corneal neovascularization: updates on pathophysiology, investigations & management","volume":"63","author":"Sharif","year":"2019","journal-title":"Rom J Ophthalmol"},{"key":"bib31","first-page":"145","article-title":"Anti-VEGF for ROP and pediatric retinal diseases","volume":"7","author":"Wu","year":"2018","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"27","author":"Falavarjani","year":"2013","journal-title":"Eye (Lond)"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1136\/bjo.2006.113902","article-title":"Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions","volume":"91","author":"Lux","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"5918","DOI":"10.1158\/1078-0432.CCR-14-1143","article-title":"An open-label phase Ib dose-escalation study of TRC105 (anti-endoglin antibody) with bevacizumab in patients with advanced cancer","volume":"20","author":"Gordon","year":"2014","journal-title":"Clin Cancer Res"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1476-4598-11-34","article-title":"Protective effect of the poly (ADP-ribose) polymerase inhibitor PJ34 on mitochondrial depolarization-mediated cell death in hepatocellular carcinoma cells involves attenuation of c-Jun N-terminal kinase-2 and protein kinase B\/Akt activation","volume":"11","author":"Radnai","year":"2012","journal-title":"Mol Cancer"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1182\/blood-2015-08-664995","article-title":"ICAM-1-expressing neutrophils exhibit enhanced effector functions in murine models of endotoxemia","volume":"127","author":"Woodfin","year":"2016","journal-title":"Blood"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1021\/nn102159g","article-title":"Nanoparticles targeting dendritic cell surface molecules effectively block T cell conjugation and shift response","volume":"5","author":"Chittasupho","year":"2011","journal-title":"ACS Nano"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"5677","DOI":"10.1242\/jcs.107987","article-title":"Intercellular adhesion molecule-1 is a regulator of blood-testis barrier function","volume":"125","author":"Xiao","year":"2012","journal-title":"J Cell Sci"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/jlb.v108.3","article-title":"ICAM-1: a master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis","volume":"108","author":"Bui","year":"2020","journal-title":"J Leukoc Biol"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/jlb.1999.66.issue-6","article-title":"Regulation of intercellular adhesion molecule-1 (CD54) gene expression","volume":"66","author":"Roebuck","year":"1999","journal-title":"J Leukoc Biol"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1289\/ehp.7457","article-title":"The induction of vascular endothelial growth factor by ultrafine carbon black contributes to the increase of alveolar-capillary permeability","volume":"113","author":"Chang","year":"2005","journal-title":"Environ Health Perspect"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"6026","DOI":"10.1016\/j.biomaterials.2014.04.015","article-title":"Tetraspecific ligand for tumor-targeted delivery of nanomaterials","volume":"35","author":"Kim","year":"2014","journal-title":"Biomaterials"}],"container-title":["Translational Vision Science & Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2783918","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T14:31:04Z","timestamp":1670596264000},"score":1,"resource":{"primary":{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2783918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12,1]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.11.12.8","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,9]]}}}